The Lupus Forum

Discussing Lupus: S1PR1-mediated modulation as a treatment target, and obinutuzumab results in SLE

24 min · 9. huhti 2026
jakson Discussing Lupus: S1PR1-mediated modulation as a treatment target, and obinutuzumab results in SLE kansikuva

Kuvaus

Professor Ed Vital and Professor Chris Edwards discuss two recent studies advancing the treatment landscape in SLE. This episode discusses S1PR1-mediated modulation of immune cell trafficking as a potential upstream therapeutic strategy in SLE, and the efficacy and safety of obinutuzumab when added to standard therapy in adults with active SLE. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of lupus care.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity The Lupus Forum-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

92 jaksot